Clinical Trial Update: Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intravesical injections of botulinum toxin A to saline for neurogenic detrusor overactivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Neurogenic Detrusor Overactivity | Phase 3 | Status: COMPLETED